Growth Metrics

Genoil (GNOLF) Shares Outstanding (Weighted Average) (2018 - 2025)

Genoil has reported Shares Outstanding (Weighted Average) over the past 8 years, most recently at $2.0 billion for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.36% to $2.0 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Sep 2025, up 2.36% year-over-year, with the annual reading at $1.9 billion for FY2024, 64.01% up from the prior year.
  • Shares Outstanding (Weighted Average) was $2.0 billion for Q3 2025 at Genoil, up from $2.0 billion in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $2.0 billion in Q3 2025 and troughed at $589.4 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $714.6 million (2023), against an average of $1.2 billion.
  • Year-over-year, Shares Outstanding (Weighted Average) dropped 4.65% in 2022 and then surged 173.42% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $618.1 million in 2021, then decreased by 4.65% to $589.4 million in 2022, then soared by 100.65% to $1.2 billion in 2023, then skyrocketed by 64.01% to $1.9 billion in 2024, then grew by 3.0% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's Shares Outstanding (Weighted Average) are $2.0 billion (Q3 2025), $2.0 billion (Q2 2025), and $2.0 billion (Q1 2025).